AXDX - Accelerate Diagnostics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
7,649
5,670
4,177
246
147
Cost of Revenue
4,238
3,187
1,002
-
0
Gross Profit
3,411
2,483
3,175
-
147
Operating Expenses
Research Development
26,049
27,638
22,301
28,196
26,022
Selling General and Administrative
51,681
55,214
45,058
36,200
17,882
Total Operating Expenses
77,730
82,852
67,359
66,747
45,696
Operating Income or Loss
-74,319
-80,369
-64,184
-66,501
-45,549
Interest Expense
13,978
10,113
0
23
23
Total Other Income/Expenses Net
-276
-478
-259
-77
0
Income Before Tax
-85,382
-88,115
-63,535
-66,107
-45,498
Income Tax Expense
-221
211
493
267
-
Income from Continuing Operations
-85,161
-88,326
-64,028
-66,374
-45,498
Net Income
-85,161
-88,326
-64,028
-66,374
-45,498
Net Income available to common shareholders
-85,161
-88,326
-64,028
-66,374
-45,498
Reported EPS
Basic
-
-1.62
-1.16
-1.29
-1.01
Diluted
-
-1.62
-1.16
-1.29
-1.01
Weighted average shares outstanding
Basic
-
54,494
54,073
51,276
44,998
Diluted
-
54,494
54,073
51,276
44,998
EBITDA
-
-75,441
-61,339
-63,733
-43,683